CBIO · Crescent Biopharma, Inc.
Market Cap
$659.30M
Shares
37.14M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1253689
CUSIP
G2545C104
13F (30d)
74 filings
74 filers
Visit website
Investor relations